| Product Code: ETC7658236 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Israel continued to see a high concentration of import shipments of pegylated proteins, with top exporting countries including Switzerland, USA, Germany, China, and Belgium. Despite a negative compound annual growth rate (CAGR) of -13.88% from 2020 to 2024, there was a positive growth rate of 8.63% from 2023 to 2024. The high Herfindahl-Hirschman Index (HHI) indicates a significant level of market concentration, suggesting that these top exporting countries have a strong presence in Israel`s pegylated proteins market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel PEGylated Proteins Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel PEGylated Proteins Market Revenues & Volume, 2021 & 2031F |
3.3 Israel PEGylated Proteins Market - Industry Life Cycle |
3.4 Israel PEGylated Proteins Market - Porter's Five Forces |
3.5 Israel PEGylated Proteins Market Revenues & Volume Share, By Product & Services, 2021 & 2031F |
3.6 Israel PEGylated Proteins Market Revenues & Volume Share, By Protein Type, 2021 & 2031F |
3.7 Israel PEGylated Proteins Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Israel PEGylated Proteins Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Israel PEGylated Proteins Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Israel leading to higher demand for pegylated proteins. |
4.2.2 Technological advancements in the development and production of pegylated proteins. |
4.2.3 Growing investments in research and development activities in the biopharmaceutical sector in Israel. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the approval and commercialization of pegylated proteins in Israel. |
4.3.2 High costs associated with the development and manufacturing of pegylated proteins. |
4.3.3 Limited awareness and understanding among healthcare professionals and patients about the benefits of pegylated proteins. |
5 Israel PEGylated Proteins Market Trends |
6 Israel PEGylated Proteins Market, By Types |
6.1 Israel PEGylated Proteins Market, By Product & Services |
6.1.1 Overview and Analysis |
6.1.2 Israel PEGylated Proteins Market Revenues & Volume, By Product & Services, 2021- 2031F |
6.1.3 Israel PEGylated Proteins Market Revenues & Volume, By Consumables, 2021- 2031F |
6.1.4 Israel PEGylated Proteins Market Revenues & Volume, By Services, 2021- 2031F |
6.2 Israel PEGylated Proteins Market, By Protein Type |
6.2.1 Overview and Analysis |
6.2.2 Israel PEGylated Proteins Market Revenues & Volume, By Colony-stimulating Factor, 2021- 2031F |
6.2.3 Israel PEGylated Proteins Market Revenues & Volume, By Interferons, 2021- 2031F |
6.2.4 Israel PEGylated Proteins Market Revenues & Volume, By Erythropoietin, 2021- 2031F |
6.2.5 Israel PEGylated Proteins Market Revenues & Volume, By Recombinant Factor VII, 2021- 2031F |
6.2.6 Israel PEGylated Proteins Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel PEGylated Proteins Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Israel PEGylated Proteins Market Revenues & Volume, By Cancer, 2021- 2031F |
6.3.3 Israel PEGylated Proteins Market Revenues & Volume, By Autoimmune Diseases, 2021- 2031F |
6.3.4 Israel PEGylated Proteins Market Revenues & Volume, By Hepatitis, 2021- 2031F |
6.3.5 Israel PEGylated Proteins Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F |
6.3.6 Israel PEGylated Proteins Market Revenues & Volume, By Hemophilia, 2021- 2031F |
6.3.7 Israel PEGylated Proteins Market Revenues & Volume, By Gastrointestinal Disorders, 2021- 2031F |
6.4 Israel PEGylated Proteins Market, By End-user |
6.4.1 Overview and Analysis |
6.4.2 Israel PEGylated Proteins Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.4.3 Israel PEGylated Proteins Market Revenues & Volume, By Contract Research Organizations, 2021- 2031F |
6.4.4 Israel PEGylated Proteins Market Revenues & Volume, By Academic & Research Institutes, 2021- 2031F |
7 Israel PEGylated Proteins Market Import-Export Trade Statistics |
7.1 Israel PEGylated Proteins Market Export to Major Countries |
7.2 Israel PEGylated Proteins Market Imports from Major Countries |
8 Israel PEGylated Proteins Market Key Performance Indicators |
8.1 Research and development expenditure in the biopharmaceutical sector in Israel. |
8.2 Number of clinical trials involving pegylated proteins conducted in Israel. |
8.3 Adoption rate of pegylated proteins in the treatment of chronic diseases in Israel. |
8.4 Number of patents filed for new technologies related to pegylated proteins in Israel. |
8.5 Rate of collaborations and partnerships between Israeli biopharmaceutical companies and international organizations for pegylated protein development. |
9 Israel PEGylated Proteins Market - Opportunity Assessment |
9.1 Israel PEGylated Proteins Market Opportunity Assessment, By Product & Services, 2021 & 2031F |
9.2 Israel PEGylated Proteins Market Opportunity Assessment, By Protein Type, 2021 & 2031F |
9.3 Israel PEGylated Proteins Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Israel PEGylated Proteins Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Israel PEGylated Proteins Market - Competitive Landscape |
10.1 Israel PEGylated Proteins Market Revenue Share, By Companies, 2024 |
10.2 Israel PEGylated Proteins Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |